## Core Concept
The question pertains to the pharmacokinetic property of drugs, specifically their half-lives (t1/2). The half-life of a drug is the time it takes for the drug's plasma concentration to reduce by half, which is crucial in determining the dosing interval and duration of action of a drug.

## Why the Correct Answer is Right
Among the given options, without specific drug names provided, we can infer based on common pharmacokinetics knowledge. Typically, drugs with longer half-lives require less frequent dosing because they stay in the system longer. For instance, drugs like **Phenobarbital** have a long half-life, often used in the management of epilepsy. Another example could be **Diazepam**, a benzodiazepine with a long half-life, used for treating anxiety, insomnia, and seizures.

## Why Each Wrong Option is Incorrect
- **Option A:** Without a specific drug listed, we can't directly assess its half-life, but generally, many drugs have half-lives that range from a few hours to a couple of days.
- **Option B:** Similarly, this option lacks specificity, but drugs with shorter half-lives (e.g., **Aspirin**, **Ibuprofen**) are commonly administered multiple times a day.
- **Option C:** This option is also unspecified, making direct comparison challenging.

## Clinical Pearl / High-Yield Fact
A key point to remember is that drugs with long half-lives can accumulate with repeated dosing, potentially leading to increased risk of toxicity. For example, **Digoxin**, used in heart failure and atrial fibrillation, has a half-life of approximately 40 hours, necessitating careful monitoring to avoid toxicity.

## Correct Answer: D.